NCT05400629

Brief Summary

20 women with myotonic dystrophy type 1 (DM1) will complete a 12-week lower-limb strength training program. The training program consist of 3 series of 6 to 8 maximal repetitions of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. Training sessions will be closely supervise and take place twice a week. It is hypothesize that the training program will induce muscular hypertrophy despite the genetic defect. The training program should also have positive effects on function. The participants will be evaluated at baseline, week 6, week 12, month 6 and month 9 to quantify the effects of the training program and if these effects will be maintained over time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 24, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 1, 2022

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2023

Completed
Last Updated

February 10, 2023

Status Verified

February 1, 2023

Enrollment Period

6 months

First QC Date

May 24, 2022

Last Update Submit

February 7, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in maximal isometric muscle strength of the knee extensors

    Changes in maximal isometric muscle strength of the knee extensors measure by quantify muscle testing using a handheld dynamometer

    At baseline, week 6, week 12, month 3 and month 6

Secondary Outcomes (37)

  • Changes in maximal isometric muscle strength of the knee flexors

    At baseline and week 12

  • Changes in maximal isometric muscle strength of the hip flexors

    At baseline and week 12

  • Changes in maximal isometric muscle strength of the hip extensors

    At baseline and week 12

  • Changes in maximal isometric muscle strength of the hip abductors

    At baseline and week 12

  • Changes in maximal isometric muscle strength of the ankle dorsiflexors

    At baseline and week 12

  • +32 more secondary outcomes

Study Arms (1)

Training program

EXPERIMENTAL

12-week strength training program of the lower limbs consisting of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. All exercises will be perform between 6 and 8 maximal repetitions.

Other: Training program

Interventions

12-week strength training program of the lower limbs consisting of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. All exercises will be perform between 6 and 8 maximal repetitions.

Training program

Eligibility Criteria

Age30 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • DM1 diagnosis must be confirmed by genetic analysis;
  • Women sex, aged between 30 and 65 years old;
  • Be able to walk without assistance;
  • Consent of the neurologist must be given to participate in this study;
  • Must reside in the Saguenay-Lac-St-Jean region;
  • Subjects must be able to give their consent freely and voluntarily.

You may not qualify if:

  • Patients with any other form of muscular dystrophy are excluded;
  • Any contraindication for strenuous exercise or muscle biopsy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe de recherche interdisciplinaire sur les maladies neuromusculaires

Saguenay, Quebec, G7X 7X2, Canada

Location

MeSH Terms

Conditions

Myotonic Dystrophy

Condition Hierarchy (Ancestors)

Muscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesMyotonic DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesNervous System DiseasesNeuromuscular DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Elise Duchesne, Ph.D

    Université du Québec à Chicoutimi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Most outcomes will not be mask, however the outcome assessor will be mask for all muscle biopsy analysis: while analysing the muscle biopsy outcomes, the outcome assessor will not know if it was from baseline or from after the training program.
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Model Details: Participants will complete a 12-week strength training program and return to their normal activities for the following 6 months after the end of the training program.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Investigator

Study Record Dates

First Submitted

May 24, 2022

First Posted

June 1, 2022

Study Start

January 1, 2022

Primary Completion

June 30, 2022

Study Completion

January 10, 2023

Last Updated

February 10, 2023

Record last verified: 2023-02

Locations